KZ

KIM ZIMMERMAN

ADVANCED MEDICAL TECHNOLOGY ASSN · WASHINGTON, DC · registered since 2024
Registered · LDAActive

At a glance

Registered since
2024
Senate LDA system
Clients
1
last 3 years
Filings
3
13 agencies contacted
Activity
filings by quarter
Works on

Background

Career
WASHINGTON, DC
2024 - present

Specific issues

Issues related to Privacy Legislation Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of diagnostic tests VALID Act of 2023 - H.R. 2369. Issues related to Health Equity Issues related to Public Health Emergency Preparedness (including Pandemic All Hazards Preparedness Act reauthorization) Issues related to the use of Artificial Intelligence Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation HR 3723 - the Medical Device Electronic Labeling Act HR 5662/S 2907 - the Medical Device Recall Improvement Act S 2672 - Improving Development and Distribution of Diagnostic Tests Act HR 3795 - Diagnostic Testing Preparedness Plan Reimbursement and coverage of focused ultrasound technology HR 1328, the Medical Device Nonvisual Accessibility Act of 2023 Issues related to FDAs third party review program
Health Issues · 2024 Q3
Issues related to R&D Expense Amortization
Taxation/Internal Revenue Code · 2024 Q3
Issues related to TRIPS Waiver Extension
Trade (domestic/foreign) · 2024 Q3
Issues related to appropriations and user fee funding for the Food and Drug Administration
Budget/Appropriations · 2024 Q3
Issues related to coverage of telehealth services Issues related to Medicare coverage for digital health technologies Issues related to physician fee schedule Issues related to H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act Issues related to S. 1000/H.R. 2377 Saving Access to Laboratory Services Act
Medicare/Medicaid · 2024 Q3
Issues related to the reauthorization of the Small Business Innovation Research (SBIR) program.
Small Business · 2024 Q3

Clients

$██,███ / qtrUnlock

Filing history

2024 Q3
ADVANCED MEDICAL TECHNOLOGY ASSN
Q3lda.gov →
2024 Q2
ADVANCED MEDICAL TECHNOLOGY ASSN
Q2lda.gov →
2024 Q1
ADVANCED MEDICAL TECHNOLOGY ASSN
Q1lda.gov →
Showing recent filings · full history on lda.gov